Voyager Therapeutics Stock Forecast

Stock Price Forecast

According to 11 analysts polled by S&P Global, Voyager Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $14.89. The average 1-year stock price forecast is 389.80% higher than the current stock price, while the lowest is $8.00 (+163.16%) and the highest is $25 (+722.37%).

Price Target: $14.89 (+389.80%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$8.00	$14.89	$12	$25
Change	+163.16%	+389.80%	+294.74%	+722.37%

Analyst Ratings

The average analyst rating for Voyager Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	12	12	12	12	11	11
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	12	12	12	12	11	11

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Sumant Kulkarni Canaccord Genuity	Canaccord Genuity	Buy Reiterates $12	Buy	Reiterates	$12	+294.74%	Jul 14, 2026
Phil Nadeau TD Cowen	TD Cowen	Buy Maintains n/a	Buy	Maintains	n/a	n/a	Jul 14, 2026
Yun Zhong Wedbush	Wedbush	Buy Maintains $8	Buy	Maintains	$8	+163.16%	Jul 14, 2026
Patrick Trucchio H.C. Wainwright	H.C. Wainwright	Buy Reiterates $25	Buy	Reiterates	$25	+722.37%	Jul 6, 2026
Debjit Chattopadhyay Guggenheim	Guggenheim	Buy Maintains $22	Buy	Maintains	$22	+623.68%	Jun 2, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

39.27M

from 40.37M

-2.73%

from 40.37M

Revenue Next Year

57.22M

from 39.27M

45.69%

from 39.27M

EPS This Year

-1.66

from -2.04

EPS Next Year

-1.56

from -1.66

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	37.42M	40.91M	250.01M	80.00M	40.37M	39.27M
Revenue Growth	-78.14%	9.33%	511.16%	-68.00%	-49.53%	-2.73%
Operating Income	-73.62M	-45.84M	122.01M	-80.51M	-128.34M	-107.36M
Net Income	-71.20M	-46.41M	132.33M	-65.00M	-119.72M	-98.50M
EPS	-	-	-	-	-2.04	-1.66
Free Cash Flow	3.94M	7.25M	-3.01M	25.61M	-83.94M	-100.40M
No. Analysts	-	-	-	-	-	11

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	125.7M
Avg	39.3M
Low	9.0M

Revenue Growth

Revenue Growth	2026	2027	2028
High	211.2%
Avg	-2.7%
Low	-77.7%

EPS Forecast

EPS	2026	2027	2028
High	-0.71
Avg	-1.66
Low	-2.17

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-